Table 4:

Examples of CAR-T cells clinical trials in T-cell Lymphomas

Target*	Identifier	Phase of study	Type of CAR-T cells	Institution/Sponsor (Country)	Status
CD30	NCT04952584	I	Allogeneic CD30.CAR-EBVST cells	Baylor College of Medicine (United States)	Recruiting
	NCT04083495	II	Autologous CD30.CART cells	University of North Carolina (United States)	Recruiting
	NCT02917083	I	Autologous CD30.CART cells	Baylor College of Medicine (United States)	Recruiting
CD30 & CCR4	NCT03602157	I	Autologous CD30.CART cells +CCR4	University of North Carolina (United States)	Recruiting
CD5	NCT03081910	I	Autologous CD5.CART cells	Baylor College of Medicine (United States)	Recruiting
	NCT04594135	I	CD5.CART cells	iCell Gene Therapeutics/Peking University People’s Hospital (China)	Recruiting
CD7	NCT03690011	I	Autologous CD7.CART cells	Baylor College of Medicine (United States)	Recruiting
	NCT05059912	II	CD7.CART cells	The First Affiliated Hospital of Soochow University (China)	Recruiting
	NCT04823091	I	Donor-derived CD7.CART cells	Wuhan Union Hospital (China)	Recruiting
	NCT05290155	I	CD7.CART cells	Shanghai General Hospital (China)	Recruiting
	NCT05377827	I	Allogeneic CD7.CART cells	Washington University School of Medicine (USA)	Not yet recruiting
CD37	NCT04136275	I	Autologous CD37.CART cells	Massachusetts General Hospital (United States)	Recruiting
CD4	NCT04162340	I	Autologous CD4.CART cells	iCell Gene Therapeutics (China)	Recruiting
	NCT04712864	I	Autologous CD4.CART cells	Legend Biotech USA Inc (Multi-center) (United States)	Active, not recruiting
CD147	NCT05013372	Early phase I	CD147.CART cells	Peking University People’s Hospital (China)	Not yet recruiting

^*This table includes examples of studies investigating each target and not inclusive of all the ongoing studies listed on clinicaltrials.gov.